Kite To Acquire Tmunity Therapeutics To Pursue Next Generation Car T-Cell Therapy Advancements In Cancer
Acquiring Company
Kite
Acquired Company
Tmunity Therapeutics, Inc.
Santa MonicaPhiladelphiaManufacturingBiotechnologyTherapeuticsManufacturingBiotechnologyHealthcareTherapeuticsDescription
Kite, a Gilead Company (Nasdaq: GILD), and Tmunity Therapeutics (Tmunity), today announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies. The acquisition of Tmunity complements Kite’s existing in-house cell therapy research capabilities by adding additional pipeline assets, platform capabilities, and a strategic research and licensing agreement with the University of Pennsylvania (Penn).
Quick answer
Kite is acquiring Tmunity Therapeutics, Inc., announced December 20, 2022. Kite is based in Santa Monica, California, United States.
- Who acquired Tmunity Therapeutics, Inc?
- Kite agreed to acquire Tmunity Therapeutics, Inc. on December 20, 2022.
- How much did Kite pay for Tmunity Therapeutics, Inc?
- The deal value was not disclosed.
- What does Kite do?
- Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer.
- Where are Kite and Tmunity Therapeutics, Inc. based?
- Kite is based in Santa Monica, California, United States. Tmunity Therapeutics, Inc. is based in Philadelphia, Pennsylvania, United States.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Merck Completes Tender Offer To Acquire Imago Biosciences, Inc. (January 11, 2023)
- Merck To Acquire Imago Biosciences, Inc. (November 21, 2022)
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
- Shockwave Medical Announces Agreement To Acquire Neovasc (January 17, 2023)
- Shockwave Medical To Acquire Neovasc (January 17, 2023)
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
Who to call at Kite, and when
When Kite changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Kite raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kite, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kite. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kite makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Tmunity Therapeutics, Inc.?
Tmunity Therapeutics, Inc. was acquired by Kite, based in Santa Monica. The deal was reported on December 20, 2022. Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. Kite is privately held and operates in Manufacturing.
When did Kite acquire Tmunity Therapeutics, Inc.?
Kite's acquisition of Tmunity Therapeutics, Inc. was reported on December 20, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Tmunity Therapeutics, Inc. do?
Tmunity is a private, clinical-stage biotechnology company focused on transforming the future of CAR-T therapies by developing the next generation of engineered T-cell therapies, innovative manufacturing process and technologies. It is privately held, operating in Manufacturing, and is based in Philadelphia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.